ÂÜÀòÂÒÂ×

Mr. Brunel joined Velocity Sciences in 2021 serving as its CEO and on its Board of Directors.

Mr. Brunel was a co-founder, board member, and CEO of Biodesix from 2006 to 2020, a company that develops and commercializes non-invasive blood-based molecular diagnostic tests for oncology. Prior to Biodesix, Mr. Brunel was co-founder and President of SomaLogic, a company creating protein capture arrays for sensitive, high-throughput, quantitative diagnostics. He was also the founder and CEO of Unidata, Inc. which merged with Vmark Software to create Ardent Software, Inc., where he served as President and as a board member until its sale to Informix.

He served as CEO of Codestream, Ltd, acquired by Blue Phoenix Solutions, eMotion, Inc., acquired by Corbus (now part of Getty Images), and as the Chairman of Xyleme, Inc. until its sale to Bow River Capital. Additionally, Mr. Brunel is currently Chairman of the board of KromaTid, Anark Corporation, and AmideBio and on the board of HepQuant, and InOn Health.

David has a BS in Chemistry from Colorado State University and MA in International Studies from Denver University.